Skip to main content
. 2008 Jan 23;10(1):202. doi: 10.1186/ar2341

Figure 2.

Figure 2

Graphic representation of the study plan of the ongoing TRIAL V (Tumor necrosis factor blockade with Remicade In Active Lupus nephritis class V) randomized placebo-controlled clinical trial. More details can be found at [76]. ACE, angiotensin-converting enzyme; WHO, World Health Organization.